BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 20335051)

  • 1. Viral safety and extraneous agents testing for veterinary vaccines: rationale for requirements, the European approach.
    Bruckner L
    Biologicals; 2010 May; 38(3):338-9. PubMed ID: 20335051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral safety and extraneous agents testing for veterinary vaccines.
    Dodet B; Hesselink W; Jungbäck C; Léchenet J; Pastoret PP; Vannier P; Vicari M
    Biologicals; 2010 May; 38(3):326-31. PubMed ID: 20503495
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of requirements in the European Union and United States of America for pre-clinical viral safety testing of veterinary vaccines.
    Sheridan S; Coughlin J
    Biologicals; 2010 May; 38(3):340-5. PubMed ID: 20400329
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
    Jungbäck C; Motitschke A
    Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current challenges in viral safety and extraneous agent testing.
    Mackay D; Kriz N
    Biologicals; 2010 May; 38(3):335-7. PubMed ID: 20338787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human and animal vaccine contaminations.
    Pastoret PP
    Biologicals; 2010 May; 38(3):332-4. PubMed ID: 20456974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring veterinary vaccines for contaminating viruses.
    Ottiger HP
    Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the conference Viral Safety and Extraneous Agents Testing for Veterinary Vaccines, Annecy, France, 25-27 October 2009.
    Biologicals; 2010 May; 38(3):325-92. PubMed ID: 20806482
    [No Abstract]   [Full Text] [Related]  

  • 9. Testing for viral contaminants of veterinary vaccines in Hungary.
    Kulcsar G; Farsang A; Soos T
    Biologicals; 2010 May; 38(3):346-9. PubMed ID: 20338783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, standardization and assessment of PCR systems for purity testing of avian viral vaccines.
    Ottiger HP
    Biologicals; 2010 May; 38(3):381-8. PubMed ID: 20338785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. European Pharmacopoeia (EP), USDA and MAFF standards--will they ever be harmonised under the VICH umbrella?
    Castle P
    Dev Biol (Basel); 2005; 121():227-34. PubMed ID: 15962485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral safety in homoeopathic medicinal products.
    Schultz N; Franck-Karl G; Schilk J; Rose N
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):55-65. PubMed ID: 21619856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laboratory host systems for extraneous agent testing in avian live virus vaccines: problems encountered.
    Philipp HC; Kolla I
    Biologicals; 2010 May; 38(3):350-1. PubMed ID: 20335050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of PCR for extranous agent testing in avian vaccines.
    Ottiger HP
    Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low levels of extraneous agents in vaccine starting materials.
    Rouby JC
    Biologicals; 2010 May; 38(3):354-7. PubMed ID: 20347331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre-validation study for testing of avian viral vaccines for extraneous agents by PCR.
    Bruckner L; Ottiger HP
    Pharmeuropa Bio; 2007 Dec; 2007(1):15-8. PubMed ID: 18413134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potency testing of veterinary vaccines for animals: the way from in vivo to in vitro. Workshop summary.
    Dev Biol (Basel); 2012; 134():149-52. PubMed ID: 22888608
    [No Abstract]   [Full Text] [Related]  

  • 18. Duration of protection in animals: the point of view of regulators.
    Bruckner L
    J Comp Pathol; 2010 Jan; 142 Suppl 1():S109-10. PubMed ID: 19896675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Excipients: regulatory aspects].
    Artiges A
    Therapie; 1999; 54(1):15-9. PubMed ID: 10216417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A ranking of European veterinary medicines based on environmental risks.
    Kools SA; Boxall A; Moltmann JF; Bryning G; Koschorreck J; Knacker T
    Integr Environ Assess Manag; 2008 Oct; 4(4):399-408. PubMed ID: 18563959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.